OncoCyte
OCX
$2.93
Share price
-3.93%
Change (1 day)
1,173.91%
Change (1 year)
Categories
OncoCyte (OCX) - P/B ratio
P/B ratio as of May 2024 : 1.91
According to OncoCyte
's latest financial reports the company has a price-to-book ratio of 1.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OncoCyte - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.01 | -9.12% |
| 2022-12-31 | 1.11 | -63.82% |
| 2021-12-31 | 3.07 | -36.07% |
| 2020-12-31 | 4.80 | 15.36% |
| 2019-12-31 | 4.16 | -74.62% |
| 2018-12-31 | 16.4 | -50.61% |
| 2017-12-31 | 33.2 | 61.72% |
| 2016-12-31 | 20.5 | 34.72% |
| 2015-12-31 | 15.2 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.76 | 44.06% | 🇺🇸 USA |